A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage

MRI May Improve Detection of DCIS

According to the results of a study presented at the 2007 annual meeting of the American Society of Clinical Oncology, magnetic resonance imaging (MRI) is more likely than mammography to detect ductal carcinoma in situ (DCIS) of the breast, and appears to be particularly good at detecting high-grade DCIS.

The goal of cancer screening is to detect cancer at an early stage, when treatment will be most successful. For the early detection of breast cancer, the American Cancer Society recommends an annual mammogram and clinical breast exam starting at the age of 40. In addition to mammography, women at high-risk of breast cancer are advised to receive annual screening with breast magnetic resonance imaging (MRI). MRI has been reported to detect more breast cancers than mammography, but is also much more expensive and more likely to produce false-positive test results.

To compare mammography to MRI for the detection of DCIS, researchers conducted a study among almost 6,000 women who were screened with both MRI and mammography. A total of 167 cases of DCIS were diagnosed among study participants.

  • MRI detected 92% of the DCIS cases and mammography detected 56% of the cases.
  • The 12 cases of DCIS that were detected only by mammography tended to be low-grade (less aggressive).
  • Of the cases of high-grade, roughly half were detected by both MRI and mammography, and half were detected only by MRI.

Comments: This study suggests that MRI may be better than mammography at detecting DCIS—particularly high-grade DCIS. It should be noted, however, that this study was performed at a highly-specialized center with extensive experience with MRI.

Reference: Kuhl CK, Schrading S, Wardelmann E, Braun M, Kuhn W, Schild HH. Magnetic resonance imaging versus mammography for diagnosing ductal carcinoma in situ. Proceedings of the American Society of Clinical Oncology. Chicago/ IL.  2007. Abstract # 1504.

 

Related News:

MRI Screening Advised for Women at High Risk of Breast Cancer (3/29/2007)

MRI Detects Cancer in Contralateral Breast Missed by Mammography in Women with Recently Diagnosed Breast Cancer (3/29/2007)

MRI May Increase Breast Cancer Detection in High-Risk Women (2/9/2007)

Breast MRI May Influence Surgery Decisions (8/24/2006)

MRI Cost-Effective for Selected Women with BRCA1 or BRCA2 Mutations (5/26/2006)

MRI Prior to Surgery in Early Breast Cancer Helps Guide Treatment Decisions (10/25/2005)

MRI More Effective than Mammography for BRCA1 and BRCA2 Carriers (9/21/2004)

MRI More Effective than Mammography for Women at High-Risk of Breast Cancer (8/6/2004 4:10:22 PM)

Preoperative MRI Helps in Determining Extent of Surgery for Breast Cancer (7/22/2003)

German Researchers Suggest MRI to Replace Screening Mammography for Familial Breast Cancer (6/4/2003)

 

 

Newsletters
Register in our member center today to receive a monthly newsletter with conference coverage updates.
Learn More »
Practice Resources
Learn how to have our conference coverage on your website.
Learn More »
Related News Stories
Maintenance Rituxan® Is Safe for Follicular Lymphoma (7/8/2008)

Gemcitabine, Rituximab, Oxaliplatin, and Pegfilgrastim Active for Relapsed NHL (6/27/2008)

Lumiliximab and FCR Promising for Relapsed CLL (6/26/2008)

Flavopiridol Has Significant Activity in Relapsed Chronic Lymphocytic Leukemia (6/25/2008)

Sprycel® Effective for Patients with Newly Diagnosed CML (6/24/2008)

Tasigna® Effective for Patients with Newly Diagnosed CML (6/24/2008)

Patients with KRAS Mutation Do Not Benefit from EGFR Inhibitors (6/20/2008)

Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer (6/20/2008)

Does a 10-year 10% Continuous Complete Remission Rate for Myeloma Patients Suggest Cure? (6/19/2008)

Radiation Therapy for Prostate Cancer Increases Incidence of AML (6/18/2008)

Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia (6/17/2008)

Statins May Reduce Acute Graft-versus-host Disease (6/17/2008)

Provigil®, a Eugeroic Agent, Improves Severe Cancer-related Fatigue (6/13/2008)

Results of Treating NHL Patients over the Age of 80 Reported at ASCO (6/12/2008)

Single-dose Carboplatin Confirmed as Effective as Radiation Therapy for Stage I Seminoma (6/12/2008)

Dose-dense Chemotherapy Effective for Localized Ewing’s Sarcoma (6/11/2008)

Mayo Clinic Reports Increasing Use of Mastectomy for Early-stage Breast Cancer (6/11/2008)

Brachytherapy May Be Treatment of Choice for Endometrial Cancer (6/10/2008)

Gemzar® Improves Survival in Early Pancreatic Cancer (6/9/2008)

Addition of Tykerb® to Herceptin® Improves Time to Progression in Herceptin Pre-treated Breast Cancer (6/6/2008)

Addition of Avastin® to Taxotere® Improves Progression-free Survival in Advanced HER2-negative Breast Cancer (6/6/2008)

Nexavar® Delays Progression of Heavily Pre-treated NSCLC (6/6/2008)

Acupuncture Reduces Pain after Neck Dissection (6/6/2008)

VePesid®/Platinol® Remains Standard of Care for Small Cell Lung Cancer (6/6/2008)

Blood Test Shows Promise for Early Detection of Lung Cancer (6/6/2008)

Tykerb® Monotherapy Active in HER2-positive Refractory Inflammatory Breast Cancer (6/6/2008)

CDX-110 Vaccine May Improve Survival in Brain Cancer (6/5/2008)

Sites of Relapse in Breast Cancer May Require Biopsy to Accurately Determine HER2 or Hormone Status (6/5/2008)

Study Confirms Efficacy of Sutent® for Initial Treatment of Metastatic Renal Cell Cancer (6/4/2008)

Conventional Chemotherapy Outperforms Xeloda® in Older Breast Cancer Patients (6/4/2008)




© 1998-2007 CancerConsultants.com  All Rights Reserved.